MARKET NEWS


Catalent to Acquire Cell Therapy Manufacturing Facility From Bone Therapeutics
XOMA Earns $25-Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 2 Clinical Study
Taconic Biosciences Launches Critical Model for COVID-19 Research
Orasis Pharmaceuticals Announces Initiation of Phase 3 Clinical Studies of Novel Eye Drop Candidate
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
miRagen Therapeutics Announces Acquisition of Viridian Therapeutics
Evonik Launches Ready-to-Use Powder Premix to Improve Processing, Appearance & Swallowability of Oral Drug Products With an Immediate-Release Profile

  FEATURED EDITORIAL


  COMPANY PROFILE

Founded in 1972 Freund-Vector Corporation is a global market leader in the design, manufacturing of solid dosage processing equipment and services for the processing of powders, particles, beads and tablets. Freund Corporation of Tokyo, Japan, our parent company and a long-time business partner, purchased controlling interest of Freund-Vector Corporation in 1997. Together our two companies now have over 5500 worldwide equipment installations in 55 countries of the world. Click here for more.

  EXCLUSIVE ONLINE CONTENT

APPLY NOW ! - A Novel Approach for Incentivizing Drug Delivery Innovation

APPLY NOW ! - A Novel Approach for Incentivizing Drug Delivery Innovation

One of the most critical early steps in the development of novel drug delivery systems is to demonstrate convincing proof-of-concept. The dilemma is that while pharma companies can be interested in….

Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company

Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company

Vedere Bio, Inc. recently announced it has been acquired by Novartis. Shareholders in Vedere Bio received $150 million upfront and….

Nemera to Acquire Copernicus to Boost Parenteral Product Portfolio & Small Series Capabilities

Nemera to Acquire Copernicus to Boost Parenteral Product Portfolio & Small Series Capabilities

Nemera recently announced it has entered into an agreement to acquire Copernicus, which specializes in the development and manufacturing of injection devices…

Apellis & Sobi Enter Collaboration for Global Co-Development & Ex-US Commercialization of Systemic Pegcetacoplan 

Apellis & Sobi Enter Collaboration for Global Co-Development & Ex-US Commercialization of Systemic Pegcetacoplan 

Apellis Pharmaceuticals, Inc. and Swedish Orphan Biovitrum AB recently announced a strategic collaboration to accelerate the advancement of systemic pegcetacoplan, a targeted….

Bayer Acquires Company to Broaden Innovation Base in Cell & Gene Therapy

Bayer Acquires Company to Broaden Innovation Base in Cell & Gene Therapy

Bayer AG recently announced the acquisition of Asklepios BioPharmaceutical, Inc., a US-headquartered biopharmaceutical company specialized in the research, development, and manufacturing of gene therapies across different therapeutic areas…..